Sponsor Pipeline

Actinium Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT02665065 Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or… Acute Myeloid Leukemia Active, Not Recruiting
Phase 2/3
NCT07157514 Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in… Acute Leukemia Not Yet Recruiting
Disease Areas
Leukemia (2) Acute Myeloid Leukemia (AML) (2)
Get alerts when Actinium Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free